HINJ Hosts HERHealth: Advancing Women’s Care from Motherhood to Menopause in Edison on September 26, 2025

On Friday, September 26, the HealthCare Institute of New Jersey (HINJ) will present HERHealth: Advancing Women’s Care from Motherhood to Menopause – a half-day educational summit exploring how pharma, med tech, policy and research can transform women’s health through every stage of life.
The event will feature dynamic panels featuring experts across a variety of sectors speaking to the industry’s impact on patients across the globe, as well as New Jersey’s economy and workforce. Attendees will also have the opportunity to network and engage with leaders and policymakers.
WHEN: Friday, September 26, 2025
8 a.m. to 12 p.m.
WHERE: West Hall at Middlesex College
2600 Woodbridge Avenue, Edison, NJ 08818
PANEL INFORMATION:
Panel 1: “HERHealth - The Science of Possibility: Innovation in Fertility, Family Planning & Maternal Health”
From fertility and contraception to maternal health and postpartum care, this panel explores how pharma and med tech companies are transforming reproductive health through science, data, and patient-driven innovation. Join us for a deep dive into what’s possible when women’s health and R&D align.
Panel 2: “HERHealth - The Menopause Moment: R&D, FemTech & the Future of Midlife Health”
Menopause is finally getting the attention it deserves. This conversation brings together the voices leading the charge to reimagine midlife health through breakthrough therapies, digital tools, and more innovative care models. From symptom tracking to stigma-smashing, we’ll explore how innovation is reshaping the menopause experience.
Panel 3: “HERHealth - From Underserved to Unstoppable: Why Women’s Health Is the Smartest Investment in Medicine”
Women’s health has been historically underfunded—and overlooked. But that’s changing. In this discussion, leaders from pharma, med tech, venture capital, and academia will explore why investing in women’s health is not just the right thing to do—it’s one of the smartest strategic moves in healthcare today.
CONFIRMED PANELISTS (Subject To Change):
- Sarah M. Adelman, Commissioner, NJ Department of Human Services
- Lisa Asare, President and Chief Executive Officer, NJ Maternal and Infant Health Innovation Authority
- Lisa Antonacci, PharmD, MBA, Vice President, Women's Health Service Line, Hackensack Meridian Health
- Beth Battaglino, RN-C, President and CEO, HealthyWomen
- Catherine Charbonneau, PharmD, MSc, Director, Field Medical Engagement, Women's Healthcare, Bayer US Medical Affairs
- Rafael Chaves, MD, US Head of Medical Affairs, Organon
- Barbara Collura, Former President and Chief Executive Officer, RESOLVE: The National Infertility Association
- Jeanann Sousou Coppola, DNP, CNM, CNE, C-EFM, FACNM, Clinical Associate Professor, Rutgers-Camden School of Nursing
- Melissa Feldman, New Jersey State Captain, RESOLVE: The National Infertility Association
- Leighann Forbes, PhD, Vice President, Medical Affairs, Neuroscience, Johnson & Johnson
- Assemblywoman Carol Murphy, Chair, Assembly Health Committee
- Robin L. Perry, MD, MSEd, Chief and Chair, Department of Obstetrics and Gynecology, Cooper University Hospital, Cooper Medical School of Rowan University
- Deidre Washington, PhD, Director, Health Equity, AdvaMed
For more information, visit: https://mtap.io/event/HERHealthAdvancingWomensCarefromMotherhoodtoMenopause.
Media can register by contacting: Steve Issenman (issenman@hinj.org)
or
Lauren Schiavo (lauren@thomasboyd.com)
# # #
About the HealthCare Institute of New Jersey (HINJ)
Founded in 1997, the HealthCare Institute of New Jersey (HINJ) is a trade association that serves as the voice for our state’s leading research-based biopharmaceutical and medical technology companies. HINJ strives to raise awareness, understanding and public support for the state’s life sciences industry, expand patient access to the medical innovations our member companies produce and promote awareness of the life sciences’ economic impact in New Jersey.
